Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Iannessi

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|April 3, 2023
Breaking down the RECIST 1.1 double read variability in lung trials: What do baseline assessments tell us?Antoine Iannessi, Hubert Beaumont
Frontiers in Oncology|October 23, 2023
Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?Hubert Beaumont, Antoine Iannessi
Insights Into Imaging|June 16, 2021
Letter to the editor: "Not all biases are bad: equitable and inequitable biases in machine learning and radiology"Antoine Iannessi, Hubert Beaumont, Anne Sophie Bertrand
Scientific Reports|May 11, 2026
Technical performance of L3 skeletal muscle area (SMA) measurement on CT for L3 skeletal muscle index (L3SMI) assessmentHubert Beaumont, Emilie Khayat, Alexandre Thinnes, et al.
European Radiology|February 25, 2018
How reliable are ADC measurements? A phantom and clinical study of cervical lymph nodesBastien Moreau, Antoine Iannessi, Christopher Hoog, et al.
Insights Into Imaging|March 19, 2021
RECIST 1.1 and lesion selection: How to deal with ambiguity at baseline?Antoine Iannessi, Hubert Beaumont, Yan Liu, et al.
Annals of Palliative Medicine|November 19, 2019
Mental health status of cancer research center's care givers: should we worry?Anne-Sophie Bertrand, Antoine Iannessi, Pierre-Yves Marcy, et al.
Leukemia & Lymphoma|February 13, 2018
Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphomaAlessandro Stecco, Francesco Buemi, Antoine Iannessi, et al.
Frontiers in Immunology|January 6, 2025
Assessing immunotherapy response: going beyond RECIST by integrating early tumor growth kineticsMehdi Felfli, Alexandre Thinnes, Sebastien Jacques, et al.
Frontiers in Oncology|March 25, 2026
Dual-modality CAD for breast cancer screening: dealing with discordant diagnosis between mammography and tomographyHubert Beaumont, Antoine Iannessi, Thomas Louis, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|April 3, 2023
Breaking down the RECIST 1.1 double read variability in lung trials: What do baseline assessments tell us?Antoine Iannessi, Hubert Beaumont
Frontiers in Oncology|October 23, 2023
Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?Hubert Beaumont, Antoine Iannessi
Insights Into Imaging|June 16, 2021
Letter to the editor: "Not all biases are bad: equitable and inequitable biases in machine learning and radiology"Antoine Iannessi, Hubert Beaumont, Anne Sophie Bertrand
Scientific Reports|May 11, 2026
Technical performance of L3 skeletal muscle area (SMA) measurement on CT for L3 skeletal muscle index (L3SMI) assessmentHubert Beaumont, Emilie Khayat, Alexandre Thinnes, et al.
European Radiology|February 25, 2018
How reliable are ADC measurements? A phantom and clinical study of cervical lymph nodesBastien Moreau, Antoine Iannessi, Christopher Hoog, et al.
Insights Into Imaging|March 19, 2021
RECIST 1.1 and lesion selection: How to deal with ambiguity at baseline?Antoine Iannessi, Hubert Beaumont, Yan Liu, et al.
Annals of Palliative Medicine|November 19, 2019
Mental health status of cancer research center's care givers: should we worry?Anne-Sophie Bertrand, Antoine Iannessi, Pierre-Yves Marcy, et al.
Leukemia & Lymphoma|February 13, 2018
Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphomaAlessandro Stecco, Francesco Buemi, Antoine Iannessi, et al.
Frontiers in Immunology|January 6, 2025
Assessing immunotherapy response: going beyond RECIST by integrating early tumor growth kineticsMehdi Felfli, Alexandre Thinnes, Sebastien Jacques, et al.
Frontiers in Oncology|March 25, 2026
Dual-modality CAD for breast cancer screening: dealing with discordant diagnosis between mammography and tomographyHubert Beaumont, Antoine Iannessi, Thomas Louis, et al.
Pageof 4